ABSTRACT

Maple syrup urine disease (MSUD) is a rare, autosomal recessive metabolic disorder caused by a genetic defect in the metabolism of branched-chain amino acids. This metabolic disorder in children can affect tooth development and increase the prevalence of caries. During dental treatment, the systemic conditions of these patients should be considered, procedures that may create metabolic stress should be avoided, and treatment planning should be undertaken with a multidisciplinary approach. This case report examines conservative dentistry approaches in two pediatric patients diagnosed with MSUD. The study aimed to address the pain, functional, and aesthetic needs of two siblings diagnosed with MSUD, alleviate the adverse effects on gingival health, and treat tooth sensitivity. In both cases, invasive procedures were avoided, and treatments were performed using noninvasive methods whenever possible. Behavior management techniques increased patient compliance, and local anesthesia administration and procedure durations were planned with consideration of metabolic stress factors. Preventive treatments were implemented to prevent premature and unnecessary tooth loss, and patients were invited for follow-up appointments at six-month intervals. The purpose of this case report is to highlight the points to consider during dental treatment in individuals diagnosed with MSUD and to demonstrate the effectiveness of the conservative approach. 

KEYWORDS

Maple Syrup Urine Disease, MSUD, conservative management, metabolic disease, pediatric dentistry.

REFERENCES

1) Hassona Y, Alqaisi Da, Flaifl Y, Alkilani A. The oral phenotype and dental management in patients with maple syrup urine disease; case report and scoping review. BMC Oral Health. 2024;24(1):362.
2) Younes S, Elkahlout R, Kilani H, Okashah S, Sharshani HA, Rezoug Z, et al. Spectrum of genetic variants associated with maple syrup urine disease in the Middle East, North Africa, and Türkiye (MENAT): a systematic review. BMC Medical Genomics. 2025;18(1):49.
3) Hassan SA, Gupta V. Maple syrup urine disease. StatPearls [Internet]: StatPearls Publishing; 2024.
4) Ballikaya E, Yildiz Y, Koç N, Tokatli A, Uzamis Tekcicek M, Sivri HS. Oral health status of children and young adults with maple syrup urine disease in Turkey. BMC Oral Health. 2021;21(1):8.
5) Esen A, Uysal H, Sümer İ. Genel anestezi altında diş tedavisi planlanan akçaağaç şurubu idrar hastalığı olan hastada anestezik yaklaşım. 2022.
6) Van Wegberg A, MacDonald A, Ahring K, Bélanger-Quintana A, Blau N, Bosch A, et al. The complete European guidelines on phenylketonuria: diagnosis and treatment. Orphanet journal of rare diseases. 2017;12(1):162.
7) Sitta A, Ribas GS, Mescka CP, Barschak AG, Wajner M, Vargas CR. Neurological damage in MSUD: the role of oxidative stress. Cellular and molecular neurobiology. 2014;34(2):157-65.
8) Frazier DM, Allgeier C, Homer C, Marriage BJ, Ogata B, Rohr F, et al. Nutrition management guideline for maple syrup urine disease: an evidence-and consensus-based approach. Molecular genetics and metabolism. 2014;112(3):210-7.
9) Scott AI, Cusmano-Ozog K, Enns GM, Cowan TM. Correction of hyperleucinemia in MSUD patients on leucine-free dietary therapy. Molecular genetics and metabolism. 2017;122(4):156-9.
10) Boyer SW, Barclay LJ, Burrage LC. Inherited metabolic disorders: Aspects of chronic nutrition management. Nutrition in Clinical Practice. 2015;30(4):502-10.
11) Packman W, Mehta I, Rafie S, Mehta J, Naldi M, Mooney KH. Young adults with MSUD and their transition to adulthood: psychosocial issues. Journal of genetic counseling. 2012;21(5):692-703.
12) Magdy RM, Dolins KR, Nagdy H, Ali TM, Elabd HS, Hassan MA. Assessment of quality of life in families affected by maple syrup urine disease: a cross-sectional study. Journal of Pediatric Endocrinology and Metabolism. 2025;38(1):65-72.
13) Hirst L, Chakrapani A, Mubeen S. Inborn errors of metabolism and their impact in paediatric dentistry. Journal of Inherited Metabolic Disease. 2022;45(3):417-30.